Benjamin Looker

Benjamin Looker, listed as board member, appears in our data through filings on Esperion Therapeutics, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 27 January 2022 to 13 July 2026, the count stands at 16 filings.

On the market, this insider has only sold: 10 sales, €138k in total. The rest of the record consists of 5 share grants. Since January 2026: no purchases and 3 sales on the market.

Most recently, on 13 July 2026, the filings show a transaction in Esperion Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.